Then, we compared the changes in the data for Crohn’s Disease Activity Index (CDAI) and serum C-reactive protein (CRP), albumin (Alb), and hemoblogin (Hb) levels for 2 years when the patients were taking 5ASA tablets, but no significant difference was found in any case (Supplemental Table S1). The gene discussed is GSTM1; the disease is Crohn disease.